Surgical Margins: What Negative, Close, and Positive Mean in Your Pathology Peport

by Jason Wasserman MD PhD FRCPC
November 3, 2026

A surgical margin is the edge of the tissue removed during an operation. When a pathologist examines that tissue, a key question is whether any tumor reaches the edge. The answer appears in the margins section of your pathology report, and it helps your care team decide whether more treatment is needed.

Surgical margins are described differently for different organs and types of surgery. A margin result for a skin cancer, for example, uses different measurements than a margin result for rectal or pancreatic cancer. The sections below start with the basics, then explain how margins are reported for each part of the body.

What is a surgical margin?

A surgical margin is the outer surface of a piece of tissue where the surgeon cut through the body to remove a tumor or abnormal area. Surgeons try to remove a tumor with a rim of normal tissue around it, much like cutting around a bruise on an apple.

Most surgical specimens have more than one margin. A breast lumpectomy has six surfaces that face different directions in the body. A piece of bowel has two cut ends plus the fatty tissue that attached it inside the abdomen.

The margin is not the same as the edge of the tumor. Surgeons hope to see a band of normal tissue between the tumor and the margin. The width of this band is often measured and reported as the distance to the margin.

Why are surgical margins important?

Surgical margins matter because they show whether the tumor was likely removed completely, with healthy tissue around it. When tumor cells reach a margin, some of the tumor may still be in the body.

Tumor left behind can grow again in the same place, which doctors call a local recurrence. For this reason, margin status is one of the main findings used to decide whether you need another surgery, radiation therapy, or closer follow-up.

Margin status is only one part of the picture. Your team also considers the tumor type, grade, stage, and your health and preferences when planning treatment.

Which pathology specimens have surgical margins?

Surgical margins are assessed mainly when the goal of a procedure is to remove an entire tumor or abnormal area. Margins matter less, or are not reported at all, when the goal is to take a small sample for diagnosis.

Diagnostic biopsy. A biopsy, such as a core needle, punch, or shave biopsy, removes a small sample to find out what an abnormal area is. Because the goal is diagnosis rather than removal, the abnormal tissue often extends to the edge of the sample. A report that says “the lesion extends to the base” or “margins are involved” is common for biopsies and does not mean something went wrong.
Excision. An excision removes the whole abnormal area, usually with a rim of normal tissue around it. Margins are reported for most excisions because they show whether the removal was complete. Examples include an excisional biopsy of a skin lesion and a breast lumpectomy.
Resection. A resection removes part or all of an organ, such as a section of colon, a lobe of the lung, or the prostate gland. Resection reports usually describe several named margins as part of a standardized cancer report.
Fragmented specimens. Some procedures remove tissue in many small pieces, such as a bladder scraping or a polyp removed in several pieces. Margins usually cannot be assessed in these specimens because the original tissue edges can no longer be identified.

How does a pathologist examine surgical margins?

Pathologists examine surgical margins in several steps, starting before they place the tissue under the microscope. These first steps are described in the gross description section of your report.

Orientation. Surgeons often mark the specimen with stitches or clips so the pathologist knows which surface faced which direction in the body. A common approach uses a short stitch for the top (superior) surface and a long stitch for the side (lateral) surface. Orientation allows the report to name exactly which margin is involved, which tells the surgeon where to remove more tissue if needed.
Ink. The pathologist paints the outer surface of the specimen with special ink, often using a different color for each margin. The ink stays on the tissue during processing, so the true surgical edge can be seen under the microscope. Tumor cells that touch the ink are described as being “at the margin.”
Perpendicular sections. For many specimens, the pathologist cuts thin slices at a right angle to the inked surface. This shows the tumor and the margin on the same slide, which allows the distance between them to be measured.
En face or shave sections. For some margins, the pathologist shaves a thin layer from the outer surface and examines it lying flat on the slide. This method looks at a larger area of the margin, but it cannot measure how far away the tumor is. Tumor seen anywhere in an en face section is usually reported as a positive margin.
Separately submitted margins. During some operations, the surgeon removes extra thin pieces of tissue from the walls of the space left behind after the tumor is removed. Each piece is labeled with its location and sent as a separate specimen. The outer surface of each new piece then becomes the final margin in that direction.
Frozen section. Sometimes the surgeon asks for a margin to be checked while you are still in the operating room. A frozen section gives an answer within minutes, so more tissue can be removed during the same operation. The result is confirmed later when the tissue is examined using routine methods.

A pathologist cannot look at every cell on the surface of a large specimen. Instead, the margins closest to the tumor and the margins most important for that type of surgery are sampled carefully, following standardized protocols for each organ.

How are surgical margins described in your pathology report?

Pathology reports use a set of standard terms to describe surgical margins, although different labs may use different words for the same finding. The terms below are the ones you are most likely to see.

Negative margin. A negative margin means no tumor cells were seen at the inked edge of the tissue. Reports may also use the words clear, free, uninvolved, or “not involved by tumor.” A negative margin is the result surgeons aim for when removing a tumor.
Positive margin. A positive margin means tumor cells were seen touching the inked edge of the tissue. Reports may also say the margin is involved, or that tumor is “present at the margin” or “at ink.” For a few tumor types, such as rectal and pancreatic cancer, tumor very close to the edge is also counted as a positive margin.
Distance to the closest margin. Many reports give the distance in millimeters (mm) or centimeters (cm) between the tumor and the nearest margin. This measurement helps your team judge how much normal tissue surrounds the tumor. Reports may list distances to several margins or say the distance is “greater than” a certain amount.
Close margin. A close margin means the tumor does not touch the edge, but the band of normal tissue is thin. There is no single definition of close, and the cut-off depends on the tumor type and the organ. Many current standardized reports give the measured distance instead of using the word close, and your care team interprets that distance.
Location of the involved margin. When a margin is positive or very near the tumor, the report usually names which margin is affected, such as the deep margin or the medial margin. This tells the surgeon exactly where any remaining tumor would be in the body.
Extent of involvement. Some reports say whether a positive margin is focal, meaning a very small area, or extensive, meaning a larger area. Others measure the length of tumor at the margin in millimeters, which is common in prostate cancer.
Type of disease at the margin. Many reports say whether the tissue at or near the margin shows invasive cancer or a precancerous change. Precancerous changes include dysplasia and carcinoma in situ. These are reported separately because they carry different risks and may be managed differently.
Cannot be assessed. Sometimes the pathologist cannot tell whether a margin is involved. This can happen when tissue arrives in pieces, is damaged by heat from surgical tools, or was not oriented. The report may say the margin “cannot be assessed” or “cannot be determined.”

Residual tumor (R) classification

Some pathology reports and surgical notes describe surgical margins using the residual tumor (R) classification from the AJCC and UICC cancer staging systems. The R category combines the pathologist’s microscopic findings with what the surgeon saw during the operation.

R0. No tumor was left behind. The margins are negative under the microscope, and the surgeon did not see any remaining tumor.
R1. Tumor was left behind that can only be seen with a microscope. The margin is positive on the slides, but the surgeon did not see any remaining tumor.
R2. Tumor was left behind that could be seen without a microscope. This usually means the surgeon could not safely remove all of the visible tumor.
RX. The presence of remaining tumor cannot be assessed.

Not every pathology report includes an R category, and its use differs between tumor types and countries. The R category is recorded separately from the pathologic stage (pTNM) and does not change the stage.

What can make surgical margins difficult to assess?

Surgical margins are not always easy to assess, even when the pathologist follows a careful process. Several common situations can make a margin result less certain, and the report will usually describe them.

Tissue removed in pieces. When a tumor is removed in several pieces, the true edges of the original specimen can no longer be identified with certainty. This is common with large polyps and with tissue removed through a scope.
Heat damage. Surgeons often use instruments that cut with heat to control bleeding. The heat can distort cells at the edge of the tissue, a change called cautery artifact. This can make it hard to tell whether tumor cells are present at the margin.
Tissue shrinkage. Tissue can shrink after it is removed and placed in preservative. Skin and fatty tissue shrink the most, so the distance measured under the microscope may be smaller than the rim of normal tissue in the body.
Torn or disrupted surfaces. If the surface of the specimen is torn during surgery or handling, the ink may not mark the true surgical edge. The pathologist will usually mention this in the report.
Natural boundaries. Some margins sit against a structure where no more tissue can be removed, such as the skin over the breast or the muscle beneath it. A tumor near one of these boundaries may have a different meaning than a tumor near a margin deep inside the body.
Treatment before surgery. Chemotherapy or radiation before surgery can shrink a tumor into scattered groups of cells within scar tissue. Margins in these specimens can be harder to measure, so the report usually gives the distance from the closest remaining tumor cells.

How are surgical margins reported in different parts of the body?

Surgical margins are examined after almost every tumor removal, but the margins that matter most depend on the organ and the type of surgery. Many labs follow standardized cancer protocols from the College of American Pathologists (CAP) or similar groups in other countries, which list the margins to report for each operation.

Breast

Breast margins are reported after a lumpectomy, also called a partial mastectomy or breast-conserving surgery, and after a mastectomy. A lumpectomy has six named margins: anterior (toward the skin), posterior (toward the chest wall), superior, inferior, medial (toward the breastbone), and lateral (toward the armpit).

Invasive breast cancer. For invasive breast cancer treated with lumpectomy and radiation, a 2014 guideline from surgical and radiation oncology groups defined a negative margin as “no ink on tumor.” Wider margins have not been shown to further lower the risk of the cancer coming back in the same breast for most people.
Ductal carcinoma in situ (DCIS). Margins for ductal carcinoma in situ are reported separately from invasive cancer. A 2016 guideline supported a margin of at least 2 mm for DCIS treated with lumpectomy and whole-breast radiation. A smaller margin is not automatically a reason for more surgery, because your team also weighs other factors.
Shave margins. Many surgeons remove extra-thin layers of tissue from the walls of the lumpectomy cavity. When this is done, the outer surface of each shave becomes the final margin, and the report describes each one separately.
Mastectomy margins. Margins are less often a concern after a mastectomy. The current CAP protocol for DCIS notes that a deep muscle (fascial) margin on a mastectomy is unlikely to be significant on its own. The report will still describe it.
Phyllodes tumors. Most benign breast tumors do not need margins reported. Phyllodes tumors are an exception, because they can grow back if they are not completely removed.

Your report may also say whether cancer at a margin is focal or more extensive. This helps your team decide whether to offer a second operation to remove more tissue, called a re-excision. The invasive breast cancer after surgery guide explains the rest of the breast surgery report.

Skin

Skin margins are divided into peripheral margins and a deep margin. The peripheral margins, also called lateral or radial margins, are the edges around the sides of the removed skin. The deep margin is the bottom of the specimen, in the fat under the skin.

Shave and punch biopsies. Skin biopsies are usually done to make a diagnosis, so a skin tumor often extends to the edge of the sample. A biopsy report that says the margin is involved does not always mean more surgery is needed, and your doctor will decide based on the type of tumor.
Basal cell and squamous cell carcinoma. For basal cell carcinoma and squamous cell carcinoma of the skin, the report states whether tumor is present at the peripheral or deep margins. A positive margin increases the chance that the tumor will grow back in the same place, sometimes years after the first surgery.
Melanoma. For invasive melanoma, the current CAP protocol (2025) asks the pathologist to report invasive melanoma and melanoma in situ at the margins separately. Distances to the peripheral and deep margins are usually given in millimeters. This microscopic distance is different from the wider excision margin your surgeon measures on the skin during surgery.
Mohs surgery. Mohs surgery removes skin cancer in thin layers while you wait. The Mohs surgeon examines the entire edge and base of each layer under the microscope using a flat (en face) method. More tissue is removed only where cancer remains. Because margins are checked during the procedure, the results are usually recorded in a Mohs surgery report rather than a standard pathology report.
Atypical moles. For a dysplastic nevus, the report may say whether the mole reaches the margin. Whether a mole at the margin should be removed again depends on the degree of atypia and your doctor’s assessment.

Colon and rectum

Colon and rectum margins are reported for surgical resections and for polyps that contain cancer. A resection has a proximal margin, which is the cut end closer to the small bowel, and a distal margin, which is the cut end closer to the anus. It also has a radial or mesenteric margin, the cut surface of the fatty tissue that held the bowel in place.

Proximal and distal margins. In most bowel resections for colon cancer, the cut ends are well away from the tumor and are negative. The report also notes any precancerous change at an end, such as dysplasia.
Radial and circumferential margins. The radial margin is often the margin closest to the tumor. In the rectum, this surface is called the circumferential resection margin (CRM). The current CAP colorectal protocol (2025) counts this margin as positive when tumor is 1 mm or less from it, not only when tumor touches the ink.
Quality of the mesorectum. After surgery for rectal cancer, the report usually describes the mesorectum, the fatty envelope around the rectum, as complete, near complete, or incomplete. A complete, smooth mesorectum shows the tumor was removed within its natural envelope, which lowers the chance of the cancer returning.
Polyps with cancer. When cancer is found in a polyp removed during colonoscopy, the report describes the deep (stalk) margin and the side (mucosal) margins. The current CAP protocol for these specimens (2023) lists tumor at or within 1 mm of the margin as a higher-risk feature. Polyps removed in several pieces often cannot be fully assessed, which can affect whether surgery is offered.

The colorectal cancer after surgery guide explains the other parts of a bowel resection report.

Esophagus and stomach

Esophagus and stomach margins include the proximal and distal cut ends and the outer surface of the tissue. In the esophagus, the outer surface is called the radial or circumferential margin. In the stomach, the report may also describe the margins in the fatty tissue, called the omentum, that hangs from the stomach.

Cut ends. Cancers of the stomach, such as adenocarcinoma of the stomach, can spread under the surface lining farther than they appear. For this reason, the proximal and distal margins are examined carefully and are sometimes checked by frozen section during surgery.
Radial margin of the esophagus. The distance that counts as a positive radial margin in esophageal cancer differs between countries. Some protocols count only tumor at ink, while others count tumor within 1 mm, so your report will usually give the measured distance.
Endoscopic resections. Early tumors and precancerous areas, such as Barrett esophagus with dysplasia, may be removed through an endoscope. The report describes the deep margin and the side (mucosal) margins, and says whether invasive cancer or dysplasia is present at each one.

Pancreas

Pancreas margins are among the most complex margins in pathology, because the pancreas sits beside major blood vessels and the bile duct. A pancreaticoduodenectomy, also called a Whipple procedure, has several named margins, and each one is assessed separately.

Named margins in a Whipple procedure. These include the pancreatic neck margin (where the pancreas was cut), the bile duct margin, and the uncinate margin, which lies next to the superior mesenteric artery. The report may also describe the vascular groove, where the specimen sat against large veins, and the front and back surfaces of the pancreas.
Distal pancreatectomy. When the tail and body of the pancreas are removed, the main margins are the cut surface of the pancreas and the surrounding soft tissue.
The 1 mm rule. The current CAP pancreas protocol (2025) counts tumor at or within 1 mm of a margin as a positive margin. Pancreatic ductal adenocarcinoma often spreads as small scattered groups of cells, so a very thin rim of normal tissue may not be enough.
After treatment. Many people with pancreatic cancer receive chemotherapy before surgery. Treatment can leave scattered cancer cells within scar tissue, so margins are measured from the closest remaining cancer cells.

Liver

Liver margins are reported when part of the liver is removed for a tumor, such as hepatocellular carcinoma or cancer that has spread to the liver. The main margin is the cut surface of the liver tissue, called the parenchymal margin, and the report usually gives the distance from the tumor to this surface. Margins at any attached blood vessels or bile ducts may also be described.

Lung

Lung margins depend on how much lung tissue was removed. After a lobectomy, which removes a whole lobe, the report describes the bronchial margin (the cut airway) and the vascular margins. Margins on any attached chest wall or other structures are also described.

After a wedge resection, which removes a small piece of lung, the main margin is the line of surgical staples across the lung tissue. The report usually gives the distance from the tumor to the staple line. The lung cancer after surgery guide explains the rest of the lung surgery report.

Prostate

Prostate margins in a radical prostatectomy are the inked outer surface of the whole prostate gland. A positive margin means prostate cancer cells touch the ink. Reports usually include several details about a positive margin.

Location. The report names where the margin is positive. Common locations are the apex (the bottom of the gland near the urethra), the base or bladder neck, and the back and sides of the gland. Location can guide radiation planning if treatment is needed later.
Length. Many reports give the length of cancer at the margin in millimeters. Longer areas of involvement are linked to a higher chance of the PSA level rising after surgery.
Grade at the margin. Some reports give the Gleason pattern of the cancer at the margin. Higher-grade cancer at a margin carries more risk than lower-grade cancer.
Cut within the prostate. Sometimes the surgeon’s cut passes through the prostate itself rather than the tissue around it. Reports may call this an intraprostatic or capsular incision, which is recorded as a type of positive margin.

A positive margin after prostatectomy does not always mean the cancer will come back. Many people are followed with regular PSA blood tests, and other options are discussed if the PSA level rises. The radical prostatectomy report guide explains the rest of the report.

Kidney

Kidney margins depend on whether part or all of the kidney was removed. After a partial nephrectomy, the main margin is the cut surface of the kidney tissue. A positive margin is uncommon, and because many of these tumors grow slowly, it is often managed with follow-up imaging.

After a radical nephrectomy, which removes the whole kidney, the report describes the renal vein margin, the ureter margin, and the outer layer of fat around the kidney. These margins matter most for larger tumors, such as clear cell renal cell carcinoma that has grown into the renal vein.

Bladder and urinary tract

Bladder margins are reported after a radical cystectomy, which removes the whole bladder. The report describes the ureteral margins (the cut ends of the tubes from the kidneys), the urethral margin, and the soft tissue margins around the bladder.

Carcinoma in situ at a ureteral or urethral margin is reported because it can lead to new tumors in the remaining urinary tract. Ureteral margins are often checked by frozen section during surgery. Scrapings of the bladder, called transurethral resections, arrive in many pieces, so margins are not reported for those specimens. The radical cystectomy report guide explains the rest of the report.

Cervix, uterus, and vulva

Gynecologic margins vary with the procedure. A loop electrosurgical excision procedure (LEEP) or cone biopsy of the cervix has three margins, and each one is assessed for precancerous change and cancer.

LEEP and cone margins. The ectocervical margin faces the vagina, the endocervical margin faces the inside of the cervical canal, and the deep (stromal) margin is the inner cut surface. The report says whether HSIL, also called CIN 2 or CIN 3, or cancer reaches each margin. HSIL at the endocervical or deep margin is linked to a higher chance of remaining disease, so follow-up testing is usually planned.
Heat damage in LEEP specimens. LEEP uses a heated wire loop, which can distort cells at the edge of the tissue. When this happens, the report may say a margin cannot be fully assessed.
Hysterectomy. For cervical cancer, the report describes the vaginal margin and the parametrial margins, which are the tissues beside the cervix. For endometrial cancer confined to the uterus, margins are rarely involved.
Vulva. Vulvar excisions have peripheral and deep margins. The report usually gives the distance from the tumor to each margin and notes any precancerous change, such as vulvar HSIL, at the edges.

Head and neck

Head and neck margins for cancers of the mouth include the mucosal margins, which are the surface lining around the tumor. They also include the deep margin, which is the muscle and soft tissue beneath it. If part of the jaw was removed, the report also describes the bone margins.

For squamous cell carcinoma of the oral cavity, the report gives the distance from the invasive cancer to the closest margin. Many head and neck teams consider 5 mm or more a clear margin and 1 to 5 mm close, but these definitions vary. The report also notes any dysplasia at the mucosal margins, and margins are often checked by frozen section during surgery.

Thyroid

Thyroid margins are the outer surface of the thyroid gland. Because there is very little tissue around the gland, a tumor near the edge of the thyroid can reach the margin even when the gland was removed completely.

For papillary thyroid carcinoma and other thyroid cancers, the report states whether tumor reaches the margin and whether it grows into the tissue around the gland. Your team considers margin status together with these and other findings when planning follow-up.

Soft tissue and bone

Soft tissue and bone margins are especially important for sarcomas. The margin is one of the strongest predictors of whether a sarcoma will grow back in the same place. The current CAP soft tissue protocol (2024) asks for the closest margin and its distance, plus the location of any other margins closer than 0.5 cm.

Fascia at the margin. Some reports say whether a layer of tough connective tissue, called fascia, lies between the tumor and the margin. Fascia acts as a barrier to tumor spread, so even a thin margin may be adequate when fascia is intact.
Infiltrative tumors. Some sarcomas, such as myxofibrosarcoma, spread along tissue planes beyond what the surgeon can see or feel. These tumors are more likely to have positive margins and to need further surgery.
Bone margins. When a tumor in bone is removed, the report describes the bone marrow margin inside the bone, the soft tissue margins, and any vessel or nerve margins. This is part of the report for bone tumors such as osteosarcoma.

Brain, lymph nodes, and blood cancers

Surgical margins are usually not reported for brain tumors, because surrounding brain tissue cannot be removed with a rim of normal tissue. For tumors such as glioblastoma, the amount of tumor removed is judged with an MRI scan after surgery instead.

Margins are also not reported when a lymph node is removed to diagnose lymphoma, or when bone marrow is sampled. In these situations the goal is diagnosis, and the disease is treated with therapies that reach the whole body.

What happens if a surgical margin is positive or close?

A positive or close surgical margin does not always mean tumor was left in the body. The surgeon’s cut may have passed through the last few tumor cells. Heat from surgical tools may also have destroyed any cells left in the wall of the surgical site.

A negative margin lowers the risk of the tumor growing back, but it does not remove the risk completely. For this reason, follow-up is planned based on the whole report, not on the margins alone.

When a margin is positive or close, your care team may discuss one or more options with you.

Re-excision or further surgery. A second operation removes more tissue from the area where the margin was involved. This is common after breast lumpectomy and skin cancer excisions.
Radiation therapy. Radiation can treat any tumor cells that may remain near the surgical site. It may be offered instead of, or in addition to, more surgery.
Other treatment. For some cancers, treatments that travel through the body, such as chemotherapy or hormone therapy, may be considered.
Close monitoring. For some tumors, regular follow-up with exams, blood tests, or imaging is the preferred approach. This is common when more surgery would be difficult or the chance of regrowth is low.

The choice depends on the tumor type, which margin is involved, how much tumor is at the margin, and whether more tissue can be removed safely. Many cases are discussed at a meeting of specialists, often called a tumor board. The article what happens after your pathology report describes these next steps.

What if no tumor is found after a re-excision?

After a re-excision for a positive or close surgical margin, the pathology report describes the new tissue and its own margins. In many cases, no tumor is found in the new tissue.

This result is common and usually good news. It suggests the first surgery removed all or nearly all of the tumor, or that any remaining cells were destroyed during healing. It does not mean the first margin result was wrong, because the first report described only the edge of the tissue removed at that time.

If tumor is found in the re-excision, the report will again describe whether the new margins are negative. Your team will use both reports together to plan the next steps.

Questions to ask your doctor

Were the surgical margins in my report negative, close, or positive?
Which margin was closest to the tumor, and how far away was it?
Was the tissue at the margin invasive cancer or a precancerous change?
Could any of my margins not be assessed, and why?
Does my report include an R category, and what is it?
How does the margin result affect my risk of the tumor coming back?
Do I need another surgery to remove more tissue?
Would radiation or another treatment be offered because of my margins?
If I do not have more treatment, how will I be monitored?
Was my case discussed at a tumor board?
If I had a re-excision, was any tumor found in the new tissue?
Should another pathologist review my margins?